FINWIRES · TerminalLIVE
FINWIRES

Update: Mizuho Keept Price Target on Corbus Pharmaceuticals to $40, Maintains Outperform Rating

作者

-- (Updated to keep price target unchanged).

Corbus Pharmaceuticals Holdings Inc (CRBP) has an average rating of buy and mean price target of $41.67, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Price: $10.06, Change: $+0.24, Percent Change: +2.44%

相關文章